|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dieldrin | CAS 60-57-1 | ||
| C12H8Cl6O | RTECS IO1750000 | ||
|
Synonyms & Trade Names HEOD; 1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4-endo,exo-5,8-dimethanonaphthalene |
DOT ID & Guide 2761 151 |
||
|
Exposure Limits |
NIOSH REL: Ca TWA 0.25 mg/m3 [skin] See Appendix A | ||
| OSHA PEL: TWA 0.25 mg/m3 [skin] | |||
| IDLH Ca [50 mg/m3] | Conversion | ||
|
Physical Description Colorless to light-tan crystals with a mild, chemical odor. [insecticide] |
|||
|
MW: 380.9 |
BP: Decomposes |
MLT: 349°F |
Sol: 0.02% |
|
VP(77°F): 8 x 10-7 mmHg |
IP: ? |
|
Sp.Gr: 1.75 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Solid | |||
|
Incompatibilities & Reactivities Strong oxidizers, active metals such as sodium, strong acids, phenols |
|||
|
Measurement Methods NIOSH S283 (II-3) |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Headache, dizziness; nausea, vomiting, malaise (vague feeling of discomfort), sweating; myoclonic limb jerks; clonic, tonic convulsions; coma; [potential occupational carcinogen]; in animals: liver, kidney damage | |
|
Target Organs
central nervous system, liver, kidneys, skin Cancer Site [in animals: lung, liver, thyroid & adrenal gland tumors] |
|
| See also: INTRODUCTION |